Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

(d) On May 4, 2012, the Board of Directors of Albany Molecular Research, Inc. (the "Company") increased the number of members of the Board of Directors from seven to eight and appointed William S. Marth to serve as a Class II Director until the 2015 annual meeting of stockholders. The Company issued a press release announcing the appointment of Mr. Marth, the full text of which is furnished as Exhibit 99.1 hereto.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

99.1 Press Release dated May 7, 2012 issued by Albany Molecular Research, Inc.